Latest news
CU Anschutz clinical trial finds GLP-1s help curb alcohol use disorder - 9News9News · Mon, 10 Aug 2026 03:56:00 GMTCU Anschutz trial finds semaglutide pills curb alcohol use disorder - 9News9News · Mon, 10 Aug 2026 03:26:00 GMTNovo Nordisk (CPSE:NOVO B) Wins Dutch Injunction Over Compounded Semaglutide Spray - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 23:10:20 GMTEuropean Commission Approves 7.2 mg Once-Weekly Wegovy Dose for Adults With Obesity - BioPharm InternationalBioPharm International · Fri, 07 Aug 2026 19:52:06 GMTSemaglutide Showed Promise in MASH Fibrosis Trial - EMJEMJ · Fri, 07 Aug 2026 09:02:12 GMTReal-World Semaglutide Use Linked to Lower Liver Stiffness, With Benefits Beyond Weight Loss - Pharmacy TimesPharmacy Times · Thu, 06 Aug 2026 20:24:25 GMTNovo’s Dutch win sends ‘clear message’ to unapproved semaglutide sellers - Life Sciences IP ReviewLife Sciences IP Review · Thu, 06 Aug 2026 18:52:31 GMTNovo Nordisk wins Netherlands GLP-1 compounding lawsuit - pharmaphorumpharmaphorum · Thu, 06 Aug 2026 12:47:54 GMT